中国医学前沿杂志（电子版）2017，Vol.9Issue(6)：8-11,4.DOI:10.12037/YXQY.2017.06-03
2016年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南解读
The interpretation of 2016 ESC/EAS guidelines for the management of dyslipidaemias
彭道泉1
作者信息
- 1. 中南大学湘雅二医院 心血管内科,长沙 410011
- 折叠
摘要
Abstract
European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guideline for the management of dyslipidaemias was updated in 2016 on the basis of 2011 version. The revised text involved in risk stratification of atherosclerotic cardiovascular disease (ASCVD), test of lipid profile and its significance, the lipid lowering targets for patients at different ASCVD risk, life style modification, the application of lipid lowering drugs, and lipid lowering in special population.关键词
血脂/动脉粥样硬化/指南Key words
Lipid/Atherosclerosis/Guideline引用本文复制引用
彭道泉..2016年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南解读[J].中国医学前沿杂志（电子版）,2017,9(6):8-11,4.
